CDC Advanced HIV Disease
Hosted by the CDC Mycotic Diseases Branch.
New Sessions to Begin November 2020
The U.S. Centers for Disease Control and Prevention (CDC) Mycotic Diseases Branch hosted a series of webinars on Advanced HIV Care in the context of COVID-19 supported by the CDC Foundation. Sessions addressed a global audience of healthcare providers and those working in public health with French and Spanish translation. This series may be continued at a later time.
The seven 75-minute long webinars took place Wednesdays at 10 am EDT
Organizers of this series: Amir Shroufi (CDC Foundation), Tom Chiller (CDC), Alexander Jordan (CDC)
For more information please contact Amir Shroufi.
Q&A developed from the sessions from audience questions.
Session Archive
Nov 17
- Video (English)
- Video (French)
- Tom Chiller - Advanced HIV Disease Care and COVID 19
- Ana Moore (CHAI) - CD4 testing as a critical component of the AHD screening package
- Cordelia Katureebe (National AIDS Control Program, MOH, Uganda) - Expanding CD4 Access: progress and challenges
- Tom Heller - Advanced HIV disease care at Lighthouse clinics in Malawi - How far have we come
July 8
- Video (English)
- Video (French)
- Video (Spanish)
- Tom Chiller - The future of cryptococcal disease management
- Tadeo Kiiza Kandole - The semi quantitative CrAg test and its potential usefulness in CrAg screening
- Rae Wake - Potential advantages of using cryptococcal meningitis treatment regimens in pre-emptive therapy
- Joe Jarvis - What future role for liposomal amphotericin B in cryptococcal meningitis management
June 17
- Video (English)
- Video (French)
- Video (Spanish)
- Tom Chiller-Introduction-Diagnosing Advanced HIV Disease
- Ikwo Oboho - PEPFAR Guidance - Use of CD4 and the Diagnosis of AHD
- Master Chisale - Disease staging, its correlation with CD4 and challenges for identifying AHD
- Ademola Osigbesan - CHAI Optimal AHD project -Early Market Access Vehicle (EMAV)
- Zee Ndlovu - Diagnosis of AHD at different health care levels
- Chiedza Mupangari - Access to CD4 count in Zimbabwe- Current situation and next steps
June 10
- Video (English)
- Video (French)
- Video (Spanish)ID-19 pandemic (Spanish)
- Tom Chiller-Introduction-Ensuring we continue to find and manage tuberculosis & cryptococcal meningitis during COVID-19 pandemic
- Sam Phiri-Unintended Consequences of the COVID-19 response on TB program
- Yuri van der Heijden-Unintended consequences of the COVID-19 response on the TB program
- Nazir Ismail-Impact of COVID-19 interventions on TB detection
- Greg Greene-Impact of COVID on CrAg testing and cryptococcal meningitis diagnosis following lockdown in South Africa
- Santiago Izco-Integrating AHD care in TB-program activities, including home-based contact-tracing (Reach-AHD study) The experience of Manhica, Mozambique
May 27
- Video (English)
- Video (French)
- Video (Spanish)
- Tom Chiller-Screening for Cryptococcal Disease
- Katy Godfrey-PEPFAR technical guidance for AHD during COVID-19
- Naoko Doi-CD4 Testing Update
- Nathan Ford-Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV
- Heather Paulin-Session 3. Panel discussion and QandA- Implementing the AHD package of care during COVID-19 – Challenges and innovations
May 20
- Video (English)
- Video (French)
- Tom Chiller-Advanced HIV Disease (AHD) - Maintaining care in the COVID-19 response
- Amir Shroufi - Details of access to Amphotericin B, Fluconazole and Flucytosine
- Bruce Larson - Cost analysis of CM treatment options
- Lee Abdelfadil - Outline of support for relevant commodities
- Richard Borain - CHAI support for procurement of CM treatments & progress update
- Paul Nyasulu - Progress and challenges in accessing flucytosine in Malawi
- Laura Trivino-Duran - The South African flucytosine access programme
- Questions and answers
April 22
- Focus on Cryptococcal Disease (English)
- Tom Chiller-Advanced HIV Disease (AHD) - Maintaining care in the COVID-19 response
- Tom Chiller-Maladie VIH à un stade avancé (AHD) : Maintien des soins dans la réponse au COVID‐19
- Halima Dawood-5-Flucytosine experience
- David Meya-Cryptococcal Meningitis Management
- David Meya-Prise en charge de la méningite à Cryptocoques